[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hospital-Acquired Infection Control Market Research Report 2024(Status and Outlook)

July 2024 | 102 pages | ID: G575D898704DEN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission.

HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.

The Global Hospital-Acquired Infection Control Market Size was estimated at USD 5896.80 million in 2023 and is projected to reach USD 7000.17 million by 2029, exhibiting a CAGR of 2.90% during the forecast period.

This report provides a deep insight into the global Hospital-Acquired Infection Control market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hospital-Acquired Infection Control Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hospital-Acquired Infection Control market in any manner.

Global Hospital-Acquired Infection Control Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GSK

Merck

Pfizer

3M

Abbott

BD

Cepheid

Getinge Group

Market Segmentation (by Type)

Catheter-associated Urinary Tract Infections (CAUTIs)

Surgical Site Infections (SSIs)

Central Line-associated Bloodstream Infections (CLABSIs)

Respiratory Infections

Market Segmentation (by Application)

Hospitals and ICUs

Outpatient Care Centers

Long-term Care Facilities (LTCFs)

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Hospital-Acquired Infection Control Market
  • Overview of the regional outlook of the Hospital-Acquired Infection Control Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-Acquired Infection Control Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Hospital-Acquired Infection Control
1.2 Key Market Segments
  1.2.1 Hospital-Acquired Infection Control Segment by Type
  1.2.2 Hospital-Acquired Infection Control Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET COMPETITIVE LANDSCAPE

3.1 Global Hospital-Acquired Infection Control Revenue Market Share by Company (2019-2024)
3.2 Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Hospital-Acquired Infection Control Market Size Sites, Area Served, Product Type
3.4 Hospital-Acquired Infection Control Market Competitive Situation and Trends
  3.4.1 Hospital-Acquired Infection Control Market Concentration Rate
  3.4.2 Global 5 and 10 Largest Hospital-Acquired Infection Control Players Market Share by Revenue
  3.4.3 Mergers & Acquisitions, Expansion

4 HOSPITAL-ACQUIRED INFECTION CONTROL VALUE CHAIN ANALYSIS

4.1 Hospital-Acquired Infection Control Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTION CONTROL MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 Mergers & Acquisitions
  5.5.2 Expansions
  5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies

6 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-Acquired Infection Control Market Size Market Share by Type (2019-2024)
6.3 Global Hospital-Acquired Infection Control Market Size Growth Rate by Type (2019-2024)

7 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-Acquired Infection Control Market Size (M USD) by Application (2019-2024)
7.3 Global Hospital-Acquired Infection Control Market Size Growth Rate by Application (2019-2024)

8 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION BY REGION

8.1 Global Hospital-Acquired Infection Control Market Size by Region
  8.1.1 Global Hospital-Acquired Infection Control Market Size by Region
  8.1.2 Global Hospital-Acquired Infection Control Market Size Market Share by Region
8.2 North America
  8.2.1 North America Hospital-Acquired Infection Control Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Hospital-Acquired Infection Control Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Hospital-Acquired Infection Control Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Hospital-Acquired Infection Control Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Hospital-Acquired Infection Control Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 GSK
  9.1.1 GSK Hospital-Acquired Infection Control Basic Information
  9.1.2 GSK Hospital-Acquired Infection Control Product Overview
  9.1.3 GSK Hospital-Acquired Infection Control Product Market Performance
  9.1.4 GSK Hospital-Acquired Infection Control SWOT Analysis
  9.1.5 GSK Business Overview
  9.1.6 GSK Recent Developments
9.2 Merck
  9.2.1 Merck Hospital-Acquired Infection Control Basic Information
  9.2.2 Merck Hospital-Acquired Infection Control Product Overview
  9.2.3 Merck Hospital-Acquired Infection Control Product Market Performance
  9.2.4 GSK Hospital-Acquired Infection Control SWOT Analysis
  9.2.5 Merck Business Overview
  9.2.6 Merck Recent Developments
9.3 Pfizer
  9.3.1 Pfizer Hospital-Acquired Infection Control Basic Information
  9.3.2 Pfizer Hospital-Acquired Infection Control Product Overview
  9.3.3 Pfizer Hospital-Acquired Infection Control Product Market Performance
  9.3.4 GSK Hospital-Acquired Infection Control SWOT Analysis
  9.3.5 Pfizer Business Overview
  9.3.6 Pfizer Recent Developments
9.4 3M
  9.4.1 3M Hospital-Acquired Infection Control Basic Information
  9.4.2 3M Hospital-Acquired Infection Control Product Overview
  9.4.3 3M Hospital-Acquired Infection Control Product Market Performance
  9.4.4 3M Business Overview
  9.4.5 3M Recent Developments
9.5 Abbott
  9.5.1 Abbott Hospital-Acquired Infection Control Basic Information
  9.5.2 Abbott Hospital-Acquired Infection Control Product Overview
  9.5.3 Abbott Hospital-Acquired Infection Control Product Market Performance
  9.5.4 Abbott Business Overview
  9.5.5 Abbott Recent Developments
9.6 BD
  9.6.1 BD Hospital-Acquired Infection Control Basic Information
  9.6.2 BD Hospital-Acquired Infection Control Product Overview
  9.6.3 BD Hospital-Acquired Infection Control Product Market Performance
  9.6.4 BD Business Overview
  9.6.5 BD Recent Developments
9.7 Cepheid
  9.7.1 Cepheid Hospital-Acquired Infection Control Basic Information
  9.7.2 Cepheid Hospital-Acquired Infection Control Product Overview
  9.7.3 Cepheid Hospital-Acquired Infection Control Product Market Performance
  9.7.4 Cepheid Business Overview
  9.7.5 Cepheid Recent Developments
9.8 Getinge Group
  9.8.1 Getinge Group Hospital-Acquired Infection Control Basic Information
  9.8.2 Getinge Group Hospital-Acquired Infection Control Product Overview
  9.8.3 Getinge Group Hospital-Acquired Infection Control Product Market Performance
  9.8.4 Getinge Group Business Overview
  9.8.5 Getinge Group Recent Developments

10 HOSPITAL-ACQUIRED INFECTION CONTROL REGIONAL MARKET FORECAST

10.1 Global Hospital-Acquired Infection Control Market Size Forecast
10.2 Global Hospital-Acquired Infection Control Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Hospital-Acquired Infection Control Market Size Forecast by Country
  10.2.3 Asia Pacific Hospital-Acquired Infection Control Market Size Forecast by Region
  10.2.4 South America Hospital-Acquired Infection Control Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Hospital-Acquired Infection Control by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Hospital-Acquired Infection Control Market Forecast by Type (2025-2030)
11.2 Global Hospital-Acquired Infection Control Market Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hospital-Acquired Infection Control Market Size Comparison by Region (M USD)
Table 5. Global Hospital-Acquired Infection Control Revenue (M USD) by Company (2019-2024)
Table 6. Global Hospital-Acquired Infection Control Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection Control as of 2022)
Table 8. Company Hospital-Acquired Infection Control Market Size Sites and Area Served
Table 9. Company Hospital-Acquired Infection Control Product Type
Table 10. Global Hospital-Acquired Infection Control Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Hospital-Acquired Infection Control
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Hospital-Acquired Infection Control Market Challenges
Table 18. Global Hospital-Acquired Infection Control Market Size by Type (M USD)
Table 19. Global Hospital-Acquired Infection Control Market Size (M USD) by Type (2019-2024)
Table 20. Global Hospital-Acquired Infection Control Market Size Share by Type (2019-2024)
Table 21. Global Hospital-Acquired Infection Control Market Size Growth Rate by Type (2019-2024)
Table 22. Global Hospital-Acquired Infection Control Market Size by Application
Table 23. Global Hospital-Acquired Infection Control Market Size by Application (2019-2024) & (M USD)
Table 24. Global Hospital-Acquired Infection Control Market Share by Application (2019-2024)
Table 25. Global Hospital-Acquired Infection Control Market Size Growth Rate by Application (2019-2024)
Table 26. Global Hospital-Acquired Infection Control Market Size by Region (2019-2024) & (M USD)
Table 27. Global Hospital-Acquired Infection Control Market Size Market Share by Region (2019-2024)
Table 28. North America Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Hospital-Acquired Infection Control Market Size by Region (2019-2024) & (M USD)
Table 31. South America Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Hospital-Acquired Infection Control Market Size by Region (2019-2024) & (M USD)
Table 33. GSK Hospital-Acquired Infection Control Basic Information
Table 34. GSK Hospital-Acquired Infection Control Product Overview
Table 35. GSK Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 36. GSK Hospital-Acquired Infection Control SWOT Analysis
Table 37. GSK Business Overview
Table 38. GSK Recent Developments
Table 39. Merck Hospital-Acquired Infection Control Basic Information
Table 40. Merck Hospital-Acquired Infection Control Product Overview
Table 41. Merck Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 42. GSK Hospital-Acquired Infection Control SWOT Analysis
Table 43. Merck Business Overview
Table 44. Merck Recent Developments
Table 45. Pfizer Hospital-Acquired Infection Control Basic Information
Table 46. Pfizer Hospital-Acquired Infection Control Product Overview
Table 47. Pfizer Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 48. GSK Hospital-Acquired Infection Control SWOT Analysis
Table 49. Pfizer Business Overview
Table 50. Pfizer Recent Developments
Table 51. 3M Hospital-Acquired Infection Control Basic Information
Table 52. 3M Hospital-Acquired Infection Control Product Overview
Table 53. 3M Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 54. 3M Business Overview
Table 55. 3M Recent Developments
Table 56. Abbott Hospital-Acquired Infection Control Basic Information
Table 57. Abbott Hospital-Acquired Infection Control Product Overview
Table 58. Abbott Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 59. Abbott Business Overview
Table 60. Abbott Recent Developments
Table 61. BD Hospital-Acquired Infection Control Basic Information
Table 62. BD Hospital-Acquired Infection Control Product Overview
Table 63. BD Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 64. BD Business Overview
Table 65. BD Recent Developments
Table 66. Cepheid Hospital-Acquired Infection Control Basic Information
Table 67. Cepheid Hospital-Acquired Infection Control Product Overview
Table 68. Cepheid Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Cepheid Business Overview
Table 70. Cepheid Recent Developments
Table 71. Getinge Group Hospital-Acquired Infection Control Basic Information
Table 72. Getinge Group Hospital-Acquired Infection Control Product Overview
Table 73. Getinge Group Hospital-Acquired Infection Control Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Getinge Group Business Overview
Table 75. Getinge Group Recent Developments
Table 76. Global Hospital-Acquired Infection Control Market Size Forecast by Region (2025-2030) & (M USD)
Table 77. North America Hospital-Acquired Infection Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Europe Hospital-Acquired Infection Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 79. Asia Pacific Hospital-Acquired Infection Control Market Size Forecast by Region (2025-2030) & (M USD)
Table 80. South America Hospital-Acquired Infection Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Hospital-Acquired Infection Control Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Global Hospital-Acquired Infection Control Market Size Forecast by Type (2025-2030) & (M USD)
Table 83. Global Hospital-Acquired Infection Control Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Industrial Chain of Hospital-Acquired Infection Control
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-Acquired Infection Control Market Size (M USD), 2019-2030
Figure 5. Global Hospital-Acquired Infection Control Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Hospital-Acquired Infection Control Market Size by Country (M USD)
Figure 10. Global Hospital-Acquired Infection Control Revenue Share by Company in 2023
Figure 11. Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Hospital-Acquired Infection Control Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Hospital-Acquired Infection Control Market Share by Type
Figure 15. Market Size Share of Hospital-Acquired Infection Control by Type (2019-2024)
Figure 16. Market Size Market Share of Hospital-Acquired Infection Control by Type in 2022
Figure 17. Global Hospital-Acquired Infection Control Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Hospital-Acquired Infection Control Market Share by Application
Figure 20. Global Hospital-Acquired Infection Control Market Share by Application (2019-2024)
Figure 21. Global Hospital-Acquired Infection Control Market Share by Application in 2022
Figure 22. Global Hospital-Acquired Infection Control Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Hospital-Acquired Infection Control Market Size Market Share by Region (2019-2024)
Figure 24. North America Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Hospital-Acquired Infection Control Market Size Market Share by Country in 2023
Figure 26. U.S. Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Hospital-Acquired Infection Control Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Hospital-Acquired Infection Control Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Hospital-Acquired Infection Control Market Size Market Share by Country in 2023
Figure 31. Germany Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Hospital-Acquired Infection Control Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Hospital-Acquired Infection Control Market Size Market Share by Region in 2023
Figure 38. China Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Hospital-Acquired Infection Control Market Size and Growth Rate (M USD)
Figure 44. South America Hospital-Acquired Infection Control Market Size Market Share by Country in 2023
Figure 45. Brazil Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Hospital-Acquired Infection Control Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Hospital-Acquired Infection Control Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Hospital-Acquired Infection Control Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Hospital-Acquired Infection Control Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Hospital-Acquired Infection Control Market Share Forecast by Type (2025-2030)
Figure 57. Global Hospital-Acquired Infection Control Market Share Forecast by Application (2025-2030)


More Publications